← Leaderboards
Kimberly Cocce Darlington
Duke University
$100,605
Attributed
$100,605
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $34K · FY2014–16$50K$37.5K$25K$12.5K$0
'14
'15
'16
Funding mix
By agency
NIH$100,605 · 1
By mechanism
F30$100,605 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Joellen M. Schildkraut$37,778,185
- Sally A Kornbluth$13,753,524
- Tomi F Akinyemiju$9,093,478
- Marc G. Caron$32,189,154
- Jennifer Pittman Clarke$3,372,243
Others in their field
Top investigators on “Cytochrome C”
- Michal Laniado Schwartzman · New York Medical College$17,695,214
- Alberto Nasjletti · New York Medical College$17,381,172
- Valerian E Kagan · Wistar Institute$15,442,821
- Antoni Barrientos · Miami Va Health Care System$11,947,468
- Mohanish Deshmukh · Univ Of North Carolina Chapel Hill$10,743,308
- Paul R Ortiz De Montellano · University Of California San Francisco$9,703,364
Research focus
Cytochrome CAffectCisplatinComplexApoptotic Protease-Activating Factor 1BaseChemotherapeutic AgentChemotherapyCleaved CellApoptoticBypassCancer CellCancer Cell LineCancer TherapyApoptosisAdaptor Signaling ProteinCaspaseAdjuvant ChemotherapyBiochemicalCell DeathCell LineCellsCessation Of LifeDefect
Grant awards (3)
Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy$33,987
F30 · FY2016 · CA · contact PI
Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy$33,531
F30 · FY2015 · CA · contact PI
Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy$33,087
F30 · FY2014 · CA · contact PI